| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the Department of Anatomy and Program in Immunology,* University of California, San Francisco, California; Thios Pharmaceuticals Incorporated,
Emeryville, California; and the Division of Pulmonary and Critical Care Medicine,
University of Miami at Mount Sinai Medical Center, Miami Beach, Florida
The homing of lymphocytes to peripheral lymph nodes is initiated by an adhesive interaction between L-selectin on lymphocytes and PNAd, a set of sialomucins that are constitutively displayed on high endothelial venules of lymph nodes. PNAd is defined by monoclonal antibody MECA-79 that recognizes a sulfated oligosaccharide carried by the sialomucins. This epitope overlaps with 6-sulfo sialyl Lewis x, a recognition determinant for L-selectin. Previous work has shown that administration of a L-selectin monoclonal antibody blocks both late-phase airway responses and airway hyperresponsiveness in a sheep model of asthma. We show here that airway-associated lymphoid collections from lungs of allergic sheep exhibited PNAd+ venules as detected by immunostaining with MECA-79. The same vessels also expressed a GlcNAc-6-O-sulfotransferase known as HEC-GlcNAc6ST, which is known to contribute to the formation of the MECA-79 epitope in high endothelial venules of mouse lymph nodes. Intravenous administration of MECA-79 to allergic sheep significantly blunted both the late-phase airway response and airway hyperresponsiveness induced by airway allergen challenge. Furthermore, MECA-79 inhibited the accumulation of all classes of leukocytes in bronchoalveolar lavage fluid. These findings represent the first demonstration that targeting of PNAd has therapeutic efficacy in an inflammatory disease.
This article has been cited by other articles:
![]() |
B. E. Maryanoff, L. de Garavilla, M. N. Greco, B. J. Haertlein, G. I. Wells, P. Andrade-Gordon, and W. M. Abraham Dual Inhibition of Cathepsin G and Chymase Is Effective in Animal Models of Pulmonary Inflammation Am. J. Respir. Crit. Care Med., February 1, 2010; 181(3): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawashima, J. Hirakawa, Y. Tobisawa, M. Fukuda, and Y. Saga Conditional Gene Targeting in Mouse High Endothelial Venules J. Immunol., May 1, 2009; 182(9): 5461 - 5468. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xu, K. Aoyama, M. Kusumoto, A. Matsuzawa, E. C. Butcher, S. A. Michie, T. Matsuyama, and T. Takeuchi Lack of lymphoid chemokines CCL19 and CCL21 enhances allergic airway inflammation in mice Int. Immunol., June 1, 2007; 19(6): 775 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, H. Lee, L. Schaffer, T. J. Gilmartin, S. R. Head, S. Takaishi, T. C. Wang, J. Nakayama, and M. Fukuda A Distinctive Set of Genes Is Upregulated During the Inflammation-Carcinoma Sequence in Mouse Stomach Infected by Helicobacter felis J. Histochem. Cytochem., March 1, 2007; 55(3): 263 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Kasaian, D. D. Donaldson, L. Tchistiakova, K. Marquette, X.-Y. Tan, A. Ahmed, B. A. Jacobson, A. Widom, T. A. Cook, X. Xu, et al. Efficacy of IL-13 Neutralization in a Sheep Model of Experimental Asthma Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 368 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Abraham, A. Ahmed, I. Serebriakov, I. T. Lauredo, J. Bassuk, J. A. Adams, and M. A. Sackner Whole-Body Periodic Acceleration Modifies Experimental Asthma in Sheep Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 743 - 752. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |